(2S,3S,4S,5R,6R)-Methyl 6-((1R,2S,3R,4R,5R)-3-acetoxy-4-azido-6,8-dioxabicyclo[3,2,1]octan-2-yloxy)-3-((2R,3R,4R,5R,6R)-6-(acetoxymethyl)-3-azido-4,5-bis(benzyloxy)tertrahydro-2H-pyran-2-yloxy)-4,5-bi
CAS Number: 99541-27-2
Category:
Fondaparinux Sodium Intermediates
Synonyms: (2S,3S,4S,5R,6R)-Methyl 6-(((1R,2S,3R,4R,5R)-3-acetoxy-4-azido-6,8-dioxabicyclo[3.2.1]octan-2-yl)oxy)-3,5-bis(benzyloxy)-4-((2R,3R,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-carboxylate / Fondaparinux GH Trisaccharide)
GMP-compliant
Commercial supply&le stock
Various Packaging Available
Factory documentation support
Product Specifications
| CAS Number | 99541-27-2 |
|---|---|
| Molecular Formula | C51H56N6O16 |
| Molecular Weight | 1009.02 |
| Purity | 98% |
| Appearance | White to off-white solid |
| Storage Conditions | 2-8°C |
| Package | From 100g/bottle to 25kg/drum |
Applications
This compound primarily serves as a key fully/semi-synthetic trisaccharide intermediate (GH sugar fragment) for the synthesis of the anticoagulant drug fondaparinux sodium.
Quality Assurance
Can be tested according to the customer’s method of analysis.
Certificate of Analysis (COA) and Material Safety Data Sheets (MSDS) provided upon request.
